Renasant Corporation (RNST) — Fair Value Analysis

Base-case fair value (P50): $20.92 · Current price: $39.70 · Verdict: Overvalued

The Verdict on RNST

Our Monte Carlo simulations indicate RENASANT CORP (RNST) is Deeply Overvalued. With a current price of $39.70, RNST trades significantly above our median fair value (P50) of $20.92, representing a substantial -47.3% disparity. This pronounced valuation gap suggests that the market currently assigns a premium to RENASANT CORP that is not supported by our fundamental models, signaling an elevated risk profile. The unrated quality tier further complicates direct assessment of its operational and financial health compared to sector benchmarks, yet the primary takeaway remains the significant overvaluation based on projected future cash flows.

How RNST stacks up against peers

While a direct comparative analysis against specific peers is limited by RNST's unrated quality tier, the sheer magnitude of the overvaluation for RNST is critical. The current price of $39.70 stands in stark contrast to our $20.92 median fair value, indicating RENASANT CORP trades at a premium far exceeding what our comprehensive models suggest for its underlying fundamentals. This -47.3% premium suggests that even without a definitive quality rating against the sector, the stock’s current pricing reflects an optimistic outlook that may not be sufficiently grounded in its operational or financial standing. Investors should view this substantial divergence with heightened caution.

What this means for investors

For investors considering RENASANT CORP, the current price of $39.70 signals considerable downside risk based on our Monte Carlo analysis. A median fair value of $20.92 implies that a significant price correction of -47.3% would be necessary to align the stock with its intrinsic valuation, absent a material shift in fundamental performance or market perception. While a bull case scenario might offer some upside, our simulations consistently point to a Deeply Overvalued scenario for RENASANT CORP. Sign up for FairCurve to see the full bear and bull distribution and track RNST's fair value as new fundamentals are released.

Frequently Asked Questions

Is RNST overvalued or undervalued right now?

Based on our Monte Carlo simulations, RENASANT CORP (RNST) is currently Deeply Overvalued. Its current price of $39.70 is substantially higher than our median fair value (P50) of $20.92.

What is the bear case and bull case for RNST?

The full Monte Carlo distribution, including specific bear (P10) and bull (P90) target prices, along with the calculated probability of upside, is exclusively available with a free FairCurve account.

How does FairCurve calculate RNST's fair value?

FairCurve employs Monte Carlo simulation to project RNST's fair value by running thousands of forward scenarios based on its fundamental drivers, providing a robust probabilistic valuation.

How can I track RNST's fair value as it changes?

You can add RNST to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation alerts whenever new earnings reports or fundamental data are released.